Please log in to view this page
Username
Password
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
